Medicare Enrolled

Dr. Ayush Singh, MD

Neurology · Rome, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
550 REDMOND RD NW, Rome, GA 30165
7622353600
In practice since 2017 (8 years)
NPI: 1447773676 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Ayush Singh is a neurology specialist in Rome, GA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 815 Medicare services across 705 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $2,010 from 32 pharmaceutical and/or device companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 32% volume in GA $2,010 industry payments

Medicare Practice Summary

Medicare Utilization ↗
815
Medicare services
Top 32% in GA for neurology
705
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
175 $83 $158
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
145 $104 $242
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
107 $65 $181
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
72 $8 $15
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
59 $9 $45
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
59 $16 $70
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
58 $15 $65
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
28 $92 $930
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
27 $10 $60
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
24 $81 $400
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
24 $133 $609
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
19 $14 $75
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
18 $271 $885
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,010
Total received (2019-2024)
Avg $335/year across 6 years
Top 50% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
80
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,910 (95.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (5.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$925
2023
$770
2022
$232
2021
$26
2020
$44
2019
$15

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$213
Alexion Pharmaceuticals, Inc.
$100
PFIZER INC.
$97
ABBVIE INC.
$77
Biogen, Inc.
$70
Celgene Corporation
$52
UCB, Inc.
$45
ARGENX US, INC.
$36
Neurelis, Inc.
$36
SK Life Science, Inc.
$32
ACADIA Pharmaceuticals Inc
$31
Sumitomo Pharma America, Inc.
$28
Genentech USA, Inc.
$25
Eisai Inc.
$25
Microtransponder, Inc.
$22
Neurocrine Biosciences, Inc.
$19
Lilly USA, LLC
$16
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2019-2024) ›
PFIZER INC.
$223
MDD US Operations, LLC
$213
Biogen, Inc.
$184
Celgene Corporation
$131
UCB, Inc.
$127
Sumitomo Pharma America, Inc.
$100
Alexion Pharmaceuticals, Inc.
$100
ABBVIE INC.
$77
Genentech USA, Inc.
$74
ARGENX US, INC.
$61
Novartis Pharmaceuticals Corporation
$59
CSL Behring
$58
Biohaven Pharmaceutical Holding Company Ltd.
$56
Eisai Inc.
$50
Teva Pharmaceuticals USA, Inc.
$45
Lilly USA, LLC
$37
Neurelis, Inc.
$36
Corium, LLC
$35
AbbVie Inc.
$35
Neurocrine Biosciences, Inc.
$35
SK Life Science, Inc.
$32
Amgen Inc.
$31
ACADIA Pharmaceuticals Inc
$31
Otsuka America Pharmaceutical, Inc.
$29
Amneal Pharmaceuticals LLC
$26
Microtransponder, Inc.
$22
Sunovion Pharmaceuticals Inc.
$22
Lundbeck LLC
$19
Cala Health, Inc.
$17
UPSHER-SMITH LABORATORIES LLC
$16
Medtronic USA, Inc.
$15
SI-BONE, INC.
$14
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
ADLARITY · AMYVID · APTIOM · AUSTEDO · AVONEX · Adlarity · Aimovig · BOTOX · Briviact · CALA TRIO · ELIQUIS · EMGALITY · Enspryng · Evrysdi · Gocovri · Hizentra · INGREZZA · KESIMPTA · Leqembi · NUPLAZID · NURTEC ODT · Ongentys · QULIPTA · REXULTI · RYTARY · Reveal LINQ · Rystiggo · TYSABRI · ULTOMIRIS · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Rome?
Compare neurologists in the Rome area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
7
Per 100K population
7.1
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Singh performed 175 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $2,010 from 32 companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other neurologists in Rome?
Dr. Singh's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →